Cite
HARVARD Citation
Lal, H. et al. (2018). Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. Vaccine. 36 (1), pp. 148-154. [Online].